{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:17:39Z","timestamp":1791137859130,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104985","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T18:49:09Z","timestamp":1407869349000},"page":"e104985","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Li-Li","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Yao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Zhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","article-title":"History of the development of arsenic derivatives in cancer therapy","volume":"6","author":"S Waxman","year":"2001","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1182\/blood.V89.9.3487","article-title":"Delicious poison: arsenic trioxide for the treatment of leukemia","volume":"89","author":"YL Kwong","year":"1997","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"ZY Wang","year":"2008","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As<sub>2<\/sub>O<sub>3<\/sub>) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"ZX Shen","year":"1997","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V93.1.268","article-title":"Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system","volume":"93","author":"J Dai","year":"1999","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jcp.22397","article-title":"Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells","volume":"226","author":"R Eguchi","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"36062","DOI":"10.1074\/jbc.M007204200","article-title":"Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase","volume":"275","author":"P Kapahi","year":"2000","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V96.4.1525","article-title":"Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis","volume":"96","author":"GJ Roboz","year":"2000","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.etp.2008.04.011","article-title":"Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide","volume":"60","author":"X Wang","year":"2008","journal-title":"Exp Toxicol Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2141.1998.00869.x","article-title":"Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein","volume":"102","author":"Y Akao","year":"1998","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As<sub>2<\/sub>O<sub>3<\/sub>) in the treatment of acute promyelocytic leukemia: As<sub>2<\/sub>O<sub>3<\/sub> induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"GQ Chen","year":"1996","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmed.2011.10.001","article-title":"Curing APL through PML\/RARA degradation by As<sub>2<\/sub>O<sub>3<\/sub>","volume":"18","author":"V Lallemand-Breitenbach","year":"2012","journal-title":"Trends Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccr.2010.06.003","article-title":"PML\/RARA oxidation and arsenic binding initiate the antileukemia response of As<sub>2<\/sub>O<sub>3<\/sub>","volume":"18","author":"M Jeanne","year":"2010","journal-title":"Cancer Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML","volume":"328","author":"XW Zhang","year":"2010","journal-title":"Science"},{"key":"ref15","first-page":"7950","article-title":"Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells","volume":"63","author":"R Nimmanapalli","year":"2003","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"DJ Goussetis","year":"2012","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"MW Deininger","year":"2000","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003495-200767020-00010","article-title":"Imatinib: a review of its use in chronic myeloid leukaemia","volume":"67","author":"MD Moen","year":"2007","journal-title":"Drugs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.V77.5.1080.1080","article-title":"NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)","volume":"77","author":"M Lanotte","year":"1991","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10495-013-0854-2","article-title":"Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-kappaB inhibition and Bcr\/Abl protein deletion","volume":"18(9)","author":"W Wei","year":"2013","journal-title":"Apoptosis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.moh.0000148552.93303.45","article-title":"Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies","volume":"12","author":"WC Chou","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"PD Ray","year":"2012","journal-title":"Cell Signal"},{"key":"ref23","first-page":"1360","article-title":"bcr\/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors","volume":"54","author":"P Laneuville","year":"1994","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Poole LB, Hall A, Nelson KJ (2011) Overview of peroxiredoxins in oxidant defense and redox regulation. Curr Protoc Toxicol Chapter 7: Unit7 9.","DOI":"10.1002\/0471140856.tx0709s49"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.yexcr.2012.06.013","article-title":"Targeting peroxiredoxins against leukemia","volume":"319","author":"CX Liu","year":"2013","journal-title":"Exp Cell Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1101\/gad.200006.112","article-title":"Peroxiredoxins, gerontogenes linking aging to genome instability and cancer","volume":"26","author":"T Nystrom","year":"2012","journal-title":"Genes Dev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"30615","DOI":"10.1074\/jbc.272.49.30615","article-title":"Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2","volume":"272","author":"P Zhang","year":"1997","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2011-06-358705","article-title":"Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene","volume":"119","author":"S Agrawal-Singh","year":"2012","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.935","article-title":"Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells","volume":"8","author":"CX Liu","year":"2012","journal-title":"Nat Chem Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.24341","article-title":"Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia","volume":"125","author":"PE Vivas-Mejia","year":"2009","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19039","DOI":"10.1016\/S0021-9258(17)46732-9","article-title":"Cells enriched for catalase are sensitized to the toxicities of bleomycin, adriamycin, and paraquat","volume":"268","author":"MJ Speranza","year":"1993","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1080\/10428190802353617","article-title":"Catalase activity and arsenic sensitivity in acute leukemia","volume":"49","author":"E Coe","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.2005.05866.x","article-title":"Arsenic trioxide (AT) is a novel human neutrophil pro-apoptotic agent: effects of catalase on AT-induced apoptosis, degradation of cytoskeletal proteins and de novo protein synthesis","volume":"132","author":"F Binet","year":"2006","journal-title":"Br J Haematol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.1074\/jbc.M110.103564","article-title":"The in vivo toxicity of hydroxyurea depends on its direct target catalase","volume":"285","author":"T Juul","year":"2010","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"H Yuan","year":"2012","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T09:43:28Z","timestamp":1649929408000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104985"}},"subtitle":[],"editor":[{"given":"Persio Dello","family":"Sbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104985","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,12]]}}}